---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-021707"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2026-06-25T20:31:27+00:00"
generated_at: "2026-06-25T20:32:17.246223+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# AYTU terminates Metadate CD license agreement with Lannett

## Summary
- Mutual termination effective June 23, 2026; certain provisions survive per Termination Agreement.
- AYTU may continue to sell existing inventory and pay royalties until sales cease.
- Metadate CD net revenue for quarter ended March 31, 2026 was $49,000, de minimis.
- Termination Agreement will be filed as exhibit to FY 2026 10-K.

## SEC filing metadata
- accession: 0001437749-26-021707
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2026-06-25T20:31:27+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/0001437749-26-021707-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/aytu20260624c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-021707
- JSON: https://secwatch.observer/filing/0001437749-26-021707.json
- Plain text: https://secwatch.observer/filing/0001437749-26-021707.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.